Medicare Enrolled

Dr. Peter Rumore, M.D.

Rheumatology · Smithtown, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
315 MIDDLE COUNTRY RD, Smithtown, NY 11787
6313607778
In practice since 2005 (20 years)
NPI: 1245226109 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rumore from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rumore? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rumore

Dr. Peter Rumore is a rheumatology specialist in Smithtown, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rumore performed 71,945 Medicare services across 1,417 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rumore received a total of $14,971 from 40 pharmaceutical and/or device companies across 746 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rumore is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 7% volume in NY $14,971 industry payments

Medicare Practice Summary

Medicare Utilization ↗
71,945
Medicare services
Top 7% in NY for rheumatology
1,417
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,597 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
58,200 $4 $11
Denosumab injection (Prolia/Xgeva) 4,440 $18 $29
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
2,600 $11 $50
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
2,400 $34 $70
Hymovis intra-articular injection
An injection of Hymovis, a hyaluronan derivative, administered directly into a joint space.
1,440 $13 $36
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
720 $27 $150
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
392 $100 $175
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
365 $70 $250
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
329 $72 $125
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
293 $1 $2
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
252 $8 $17
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
98 $77 $198
Erythrocyte sedimentation rate (ESR) test
A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine.
93 $4 $15
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
87 $115 $539
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
84 $0 $30
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
79 $8 $30
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
40 $26 $150
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
19 $46 $325
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
14 $116 $360
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.2% high complexity
90.2% medium
1.6% routine

Industry Payment Transparency

Open Payments through 2023 ↗
$14,971
Total received (2018-2023)
Avg $2,495/year across 6 years
Top 22% in NY for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
746
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,971 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$1,807
2022
$3,727
2021
$1,918
2020
$850
2019
$3,680
2018
$2,989

Payments by company (2023)

Consulting
Speaking
Meals & Travel
Research
AbbVie Inc.
$569
UCB, Inc.
$164
Amgen Inc.
$163
Lilly USA, LLC
$145
Janssen Biotech, Inc.
$139
PFIZER INC.
$132
AstraZeneca Pharmaceuticals LP
$87
GlaxoSmithKline, LLC.
$55
Boehringer Ingelheim Pharmaceuticals, Inc.
$55
Ferring Pharmaceuticals Inc.
$51
Horizon Therapeutics plc
$45
Genentech USA, Inc.
$44
Novartis Pharmaceuticals Corporation
$38
Aurinia Pharma U.S., Inc.
$37
Radius Health, Inc.
$21
Kiniksa Pharmaceuticals, Ltd.
$18
E.R. Squibb & Sons, L.L.C.
$16
Fidia Pharma USA Inc.
$15
Sandoz Inc.
$14
Top 3 companies account for 49.6% of 2023 payments
All-time payments by company (2018-2023) ›
Amgen Inc.
$2,161
AbbVie Inc.
$1,356
PFIZER INC.
$1,241
Janssen Biotech, Inc.
$1,151
Lilly USA, LLC
$851
UCB, Inc.
$829
Genentech USA, Inc.
$728
ABBVIE INC.
$719
GlaxoSmithKline, LLC.
$666
Novartis Pharmaceuticals Corporation
$641
Horizon Therapeutics plc
$503
AbbVie, Inc.
$500
Radius Health, Inc.
$475
AstraZeneca Pharmaceuticals LP
$416
Regeneron Healthcare Solutions, Inc.
$342
Mallinckrodt LLC
$331
Mallinckrodt Enterprises LLC
$328
Aurinia Pharma U.S., Inc.
$295
Antares Pharma, Inc.
$181
MEDAC PHARMA, INC.
$173
Boehringer Ingelheim Pharmaceuticals, Inc.
$151
Celgene Corporation
$128
DePuy Synthes Sales Inc.
$127
Ferring Pharmaceuticals Inc.
$121
Flexion Therapeutics, Inc.
$73
MEDEXUS PHARMA, INC.
$72
Sobi, Inc
$70
Takeda Pharmaceuticals U.S.A., Inc.
$65
West-Ward Pharmaceuticals
$51
E.R. Squibb & Sons, L.L.C.
$35
Horizon Pharma plc
$32
Pacira Therapeutics, Inc.
$31
Exeltis, USA Inc.
$24
GRT US Holding, Inc.
$20
Kiniksa Pharmaceuticals, Ltd.
$18
Fidia Pharma USA Inc.
$15
Sandoz Inc.
$14
GENZYME CORPORATION
$14
Merck Sharp & Dohme Corporation
$13
FIDIA PHARMA USA INC.
$12
Top 3 companies account for 31.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Arcalyst · BENLYSTA · COSENTYX · Cimzia · EUFLEXXA · EVENITY · Enbrel · FORTEO · HUMIRA · HYM/HYN · Humira · Hymovis · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · MONOVISC · Mitigare · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · ORTHOVISC · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · Qutenza · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · Uloric · XELJANZ · XYOSTED · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Smithtown?
Compare rheumatologists in the Smithtown area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
60
Per 100K population
3.9
County median income
$128,329
Nearest hospital
ST CATHERINE OF SIENA HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2023
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rumore is a mixed practice specialist, with above-average Medicare volume (top 7% in NY), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rumore experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Rumore performed 58,200 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rumore receive payments from pharmaceutical companies?
Yes. Dr. Rumore received a total of $14,971 from 40 companies across 746 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rumore's costs compare to other rheumatologists in Smithtown?
Dr. Rumore's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rumore) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →